Back to search
Ollier Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ollier Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ollier Disease trials you may qualify forMultiple Osteochondromas (MO), also known as Multiple Cartilaginous Exostoses, is an autosomal dominant skeletal disorder with an incidence of approximately 1 i…
Background: Ollier disease (OD) and Maffucci syndrome (MS) are rare disorders that increase the risk of cancers in cartilage tissue. These tumors can lead to s…
The main purpose of the study is the characterization of functional and morphological alterations due to multiple osteochondromas in a pediatric and adult popul…
REM is a retrospective and prospective registry, finalized to care and research. It is articulated in main sections - strongly related and mutually dependent on…
REM is a retrospective and prospective registry, finalized for care and research purposes. It is articulated in main sections - strongly related and mutually de…
This study aims to evaluate the safety and efficacy of a novel bone substitute material for the treatment of bone defects in patients requiring defect filling f…
Background Individuals with rare skeletal disorders frequently experience psychological distress, social isolation, unmet needs, and significant challenges due…
the purpose of the present registry is to describe the epidemiology of forearm deformities in patients with Hereditary Multiple Exostoses and to identify, indep…